Central Bank & Trust Co. Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Central Bank & Trust Co. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% in the 1st quarter, HoldingsChannel reports. The fund owned 16,963 shares of the medical equipment provider’s stock after selling 177 shares during the quarter. Intuitive Surgical makes up about 1.4% of Central Bank & Trust Co.’s holdings, making the stock its 19th largest holding. Central Bank & Trust Co.’s holdings in Intuitive Surgical were worth $8,401,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $2,401,493,000. GAMMA Investing LLC boosted its stake in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock worth $14,999,630,000 after purchasing an additional 3,022,979 shares during the period. Proficio Capital Partners LLC grew its holdings in Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares in the last quarter. Capital Research Global Investors raised its position in shares of Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock valued at $1,764,904,000 after buying an additional 687,906 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $313,769,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Down 0.2%

Intuitive Surgical stock opened at $557.08 on Friday. Intuitive Surgical, Inc. has a 52-week low of $413.52 and a 52-week high of $616.00. The company’s 50 day moving average is $521.99 and its two-hundred day moving average is $539.24. The firm has a market cap of $199.67 billion, a PE ratio of 86.91, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same period in the previous year, the company earned $1.50 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 25,443 shares of company stock valued at $12,692,195. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research reports. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research report on Wednesday, April 23rd. Truist Financial decreased their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday. Evercore ISI cut their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Finally, Robert W. Baird decreased their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.